alpha-hydroxyglutarate has been researched along with Biliary Atresia in 1 studies
2-hydroxyglutarate : A dicarboxylic acid anion obtained by deprotonation of at least one of the carboxy groups of 2-hydroxyglutaric acid.
2-hydroxyglutaric acid : A 2-hydroxydicarboxylic acid that is glutaric acid in which one hydrogen alpha- to a carboxylic acid group is substituted by a hydroxy group.
Biliary Atresia: Progressive destruction or the absence of all or part of the extrahepatic BILE DUCTS, resulting in the complete obstruction of BILE flow. Usually, biliary atresia is found in infants and accounts for one third of the neonatal cholestatic JAUNDICE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tian, X | 3 |
| Wang, Y | 3 |
| Lu, Y | 3 |
| Wu, B | 3 |
| Chen, S | 3 |
| Du, J | 3 |
| Cai, W | 3 |
| Xiao, Y | 3 |
1 other study available for alpha-hydroxyglutarate and Biliary Atresia
| Article | Year |
|---|---|
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |